News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Big Pharmas Such As Bristol-Myers Squibb Company (BMY), Roche Holding AG (RHHBF.PK), And Merck & Co., Inc. (MRK) Race To Launch Breakthrough Melanoma Drugs


3/25/2014 7:33:05 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Major pharmaceutical companies are racing to launch breakthrough drugs in the next 18 months to treat advanced melanoma, the deadliest form of skin cancer. Bristol-Myers Squibb Co., Roche Holding AG and Merck & Co. each are working on a potential blockbuster "immunotherapy" drug that would use the body's immune system to fight the cancer. If approved, the three drugs could be launched between late 2014 and late 2015.

Help employers find you! Check out all the jobs and post your resume.

Read more at The Wallstreet Journal.

comments powered by Disqus


comments powered by Disqus
   
Melanoma

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES